Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 47 citing articles:

Multifunctional Biomimetic Liposomes with Improved Tumor‐Targeting for TNBC Treatment by Combination of Chemotherapy, Anti‐Angiogenesis and Immunotherapy
Jinshuai Lan, Lixia Chen, Zhe Li, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 31
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 41
Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives
Tianfeng Li, Milad Ashrafizadeh, Yuru Shang, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103851-103851
Open Access | Times Cited: 36
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 27
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10
Mu‐Yang Huang, Yu‐Chi Chen, Wen-Yu Lyu, et al.
Pharmacological Research (2023) Vol. 198, pp. 106988-106988
Open Access | Times Cited: 27
Enhanced Postsurgical Cancer Treatment Using Methacrylated Glycol Chitosan Hydrogel for Sustained DNA/Doxorubicin Delivery and Immunotherapy
Hee Seung Seo, Jun‐Hyeok Han, Jaesung Lim, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 12
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
Chunbao Zang, Yu Tian, Yujing Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Polysaccharide-Based Hydrogels for Advanced Biomedical Engineering Applications
Md. Mahamudul Hasan Rumon, Anwarul Azim Akib, Stephen Don Sarkar, et al.
ACS Polymers Au (2024) Vol. 4, Iss. 6, pp. 463-486
Open Access | Times Cited: 11
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Dongping Deng, Mengmeng Wang, Yan Su, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6810-6821
Closed Access | Times Cited: 9
Chitosan and hyaluronic acid in breast cancer treatment: Anticancer efficacy and nanoparticle and hydrogel development
Yanlin Jiang, Yu Cao, Yiqun Yao, et al.
International Journal of Biological Macromolecules (2025) Vol. 301, pp. 140144-140144
Closed Access | Times Cited: 1
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Dendrobium officinale polysaccharide-based carrier to enhance photodynamic immunotherapy
Shengchang Tao, Yuchen Song, Shaobo Ding, et al.
Carbohydrate Polymers (2023) Vol. 317, pp. 121089-121089
Closed Access | Times Cited: 15
Erythrocyte membrane-camouflaged DNA-functionalized upconversion nanoparticles for tumor-targeted chemotherapy and immunotherapy
Qinjie Kou, Yu‐Fen Huang, Yanrong Su, et al.
Nanoscale (2023) Vol. 15, Iss. 21, pp. 9457-9476
Closed Access | Times Cited: 12
The Role of Traditional Chinese Medicine in Cancer Immunotherapy: Current Status and Future Directions
Jinxin Xie, Huiming Huang, Xingxing Li, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 07, pp. 1627-1651
Closed Access | Times Cited: 12
A pH-triggered N-oxide polyzwitterionic nano-drug loaded system for the anti-tumor immunity activation research
Yan Zhao, Yuansong Bai, Mei Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Mechanistic exploration of Traditional Chinese Medicine regulation on tumor immune microenvironment in the treatment of triple-negative breast cancer: based on CiteSpace and bioinformatics analysis
Dandan Feng, Dongqing Pu, Juan Ren, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Recent advances in delivery systems of ginsenosides for oral diseases
Yuqing Gu, Ze Li, Shu Zhou, et al.
Phytomedicine (2025), pp. 156422-156422
Closed Access
Enhanced Antitumor Efficacy and Reduced Toxicity in Colorectal Cancer Using a Novel Multifunctional Rg3- Targeting Nanosystem Encapsulated with Oxaliplatin and Calcium Peroxide
Yizhuo Xie, Ming Zhu, Han Bao, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1021-1046
Open Access
Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer
Jingyi Huang, Jingbin Shi, Ninghui Ma, et al.
Phytomedicine (2025) Vol. 139, pp. 156514-156514
Closed Access
Advanced therapeutic strategies using Thermo-sensitive chitosan/pectin hydrogel in the treatment of multiple cancers
Tosha Pandya, Disha Joshi, Zenab Presswala, et al.
Carbohydrate Polymers (2025) Vol. 357, pp. 123454-123454
Closed Access
Natural Products as Novel Therapeutic Agents for Triple-Negative Breast Cancer: Current Evidence, Mechanisms, Challenges, and Opportunities
Qingzhou Li, Zhen Ye, Guilin Wang, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1201-1201
Open Access
Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review
Hyun-Su Kang, Hyun Lim, Won Young Jang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2593-2593
Open Access
Nanoparticle-Based Delivery Systems for Phytochemicals in Cancer Therapy: Molecular Mechanisms, Clinical Evidence, and Emerging Trends
Mahmoud A.H. Mostafa, Hani M. J. Khojah
Drug Development and Industrial Pharmacy (2025), pp. 1-31
Closed Access
Curcumin delivered by ROS-responsive ibuprofen prodrug based on hyaluronic acid effectively suppressed the rheumatoid arthritis
Paul H. Huang, Miaomiao Ma, Hao Wu, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106868-106868
Closed Access
Page 1 - Next Page

Scroll to top